Page last updated: 2024-08-22

platinum and Angina Pectoris, Stable

platinum has been researched along with Angina Pectoris, Stable in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boersma, E; Daemen, J; de Jaegere, PP; Diletti, R; Lemmert, ME; Regar, E; van Bommel, RJ; van Domburg, RT; van Geuns, RJ; van Mieghem, NM; Zijlstra, F	1
Dauler, M; Haldis, TA; Maehara, A; Mehran, R; Myers, P; Peng, Y; Popma Almonacid, A; Price, MJ; Shlofmitz, RA; Spriggs, DJ	1
De la Torre Hernandez, JM; Garcia Camarero, T; Gorria, GM; Lee, DH; Lerena, P; Sainz Laso, F; Zueco, J	1
Garcia-Garcia, HM; Karanasos, A; Regar, E; van Geuns, RJ	1

Trials

2 trial(s) available for platinum and Angina Pectoris, Stable

Article	Year
Safety and efficacy of the next generation Resolute Onyx zotarolimus-eluting stent: Primary outcome of the RESOLUTE ONYX core trial. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2018, 08-01, Volume: 92, Issue:2 Topics: Aged; Angina, Stable; Cardiovascular Agents; Chromium Alloys; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Iridium; Male; Middle Aged; Percutaneous Coronary Intervention; Platinum; Prospective Studies; Prosthesis Design; Risk Factors; Sirolimus; Time Factors; Treatment Outcome; Ultrasonography, Interventional; United States	2018
A real all-comers randomized trial comparing Xience Prime and Promus Element stents. The Journal of invasive cardiology, 2013, Volume: 25, Issue:4 Topics: Aged; Angina, Stable; Angina, Unstable; Chromium Alloys; Coronary Restenosis; Drug-Eluting Stents; Equipment Failure; Everolimus; Female; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platinum; Sirolimus; Thrombosis; Treatment Outcome	2013

Article

Year

Safety and efficacy of the next generation Resolute Onyx zotarolimus-eluting stent: Primary outcome of the RESOLUTE ONYX core trial.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2018, 08-01, Volume: 92, Issue:2

Topics: Aged; Angina, Stable; Cardiovascular Agents; Chromium Alloys; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Iridium; Male; Middle Aged; Percutaneous Coronary Intervention; Platinum; Prospective Studies; Prosthesis Design; Risk Factors; Sirolimus; Time Factors; Treatment Outcome; Ultrasonography, Interventional; United States

2018

A real all-comers randomized trial comparing Xience Prime and Promus Element stents.

The Journal of invasive cardiology, 2013, Volume: 25, Issue:4

Topics: Aged; Angina, Stable; Angina, Unstable; Chromium Alloys; Coronary Restenosis; Drug-Eluting Stents; Equipment Failure; Everolimus; Female; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platinum; Sirolimus; Thrombosis; Treatment Outcome

2013

Other Studies

2 other study(ies) available for platinum and Angina Pectoris, Stable

Article	Year
The Promus Premier everolimus-eluting platinum chromium stent with durable polymer evaluated in a real world all-comer population in Rotterdam cardiology hospital (the P-SEARCH registry). International journal of cardiology, 2017, Aug-01, Volume: 240 Topics: Aged; Angina, Stable; Chromium; Cohort Studies; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Netherlands; Percutaneous Coronary Intervention; Platinum; Polymers; Prospective Studies; Registries	2017
Fate of side-branch jailing and a malapposed platinum marker after resorption of an everolimus-eluting bioresorbable vascular scaffold: serial optical coherence tomography observations. JACC. Cardiovascular interventions, 2015, Volume: 8, Issue:3 Topics: Absorbable Implants; Angina, Stable; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Vessels; Everolimus; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platinum; Predictive Value of Tests; Prosthesis Design; Time Factors; Tomography, Optical Coherence; Treatment Outcome	2015

Article

Year

The Promus Premier everolimus-eluting platinum chromium stent with durable polymer evaluated in a real world all-comer population in Rotterdam cardiology hospital (the P-SEARCH registry).

International journal of cardiology, 2017, Aug-01, Volume: 240

Topics: Aged; Angina, Stable; Chromium; Cohort Studies; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Netherlands; Percutaneous Coronary Intervention; Platinum; Polymers; Prospective Studies; Registries

2017

Fate of side-branch jailing and a malapposed platinum marker after resorption of an everolimus-eluting bioresorbable vascular scaffold: serial optical coherence tomography observations.

JACC. Cardiovascular interventions, 2015, Volume: 8, Issue:3

Topics: Absorbable Implants; Angina, Stable; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Vessels; Everolimus; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platinum; Predictive Value of Tests; Prosthesis Design; Time Factors; Tomography, Optical Coherence; Treatment Outcome

2015